Panagora Asset Management’s NanoViricides NNVC Stock Holding History

Panagora Asset Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,461	Closed	-$17K	–	2573
2019 Q2	$17K	Sell	3,461 -44	-1%	-$226	﹤0.01%	2310
2019 Q1	$19K	Buy	3,505 +1,407	+67%	+$9.18K	﹤0.01%	2273
2018 Q4	$8K	Buy	+2,098	New	+$13.4K	﹤0.01%	2339

Other funds holding NNVC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Panagora Asset Management's NNVC Position: Q3 2019 in Review

Panagora Asset Management sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 3,461 shares — an estimated $17K sold.

Panagora Asset Management first reported a position in NNVC in Q4 2018 and held it in 3 quarters. The position peaked at $19K in Q1 2019. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

Panagora Asset Management reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 3,461 NanoViricides shares in Q3 2019, an estimated $17K.
Panagora Asset Management first reported a position in NanoViricides in Q4 2018 and held it in 3 quarters.
Panagora Asset Management's NanoViricides position peaked at $19K in Q1 2019.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.